How COVID-19 Revamped The U.S. Strategic National Stockpile

The transcript discusses the state of the U.S. strategic national stockpile at the start of the COVID-19 pandemic, highlighting the lack of essential medical supplies. Over a year into the pandemic, the stockpile has significantly improved, with increased inventory of masks, ventilators, gloves, and eye protection. The pandemic has led to a strategic shift in how the stockpile functions, focusing on partnerships and flexible production capabilities. Government actions, including executive orders by former President Trump and President Biden, aim to ensure preparedness for future threats. Experts emphasize the importance of continued funding to maintain readiness.

What was the state of the Strategic National Stockpile at the beginning of the pandemic?

• Fully stocked with all necessary supplies

• Lacking even basic supplies

• Prepared for future threats

• Overstocked with unnecessary items

How has the SNS changed its approach to managing supplies?

• By creating flexible supply chains and partnerships

• By relying on international suppliers

• By focusing solely on increasing stockpile size

• By reducing the number of items in stock

Which companies are part of the SNS's network for supply chain flexibility?

• Apple, Microsoft, and Google

• Amazon, Walmart, and Target

• 3M, CVS Pharmacy, and GE

• Pfizer, Moderna, and Johnson & Johnson

What actions have been taken by the U.S. government to ensure the SNS is prepared for future crises?

• Focusing only on COVID-19 related supplies

• Relying on state governments for supplies

• Reducing funding for the SNS

• Issuing executive orders to expand the stockpile

Why do experts emphasize the need for continued funding of the SNS?

• To eliminate the need for a stockpile

• To ensure preparedness for future crises

• To focus on current pandemic only

• To reduce government spending